Texas telehealth bill removes ‘face-to-face’ requirement

| | Health Exec | Telehealth

Telehealth standards could change in Texas if the state’s legislature passes newly proposed legislation removing the requirement for physicians to meet patients in-person before offering services via telehealth or prescribing any drugs.

The National Law Review reported the bill would remove one of the main reasons Texas has been given the lowest composite score for telehealth access by the American Telemedicine Association. These struggles chiefly rose from the Texas Medical Board’s concerns that Dallas-based Teladoc, one of the largest telehealth providers, would handle writing prescriptions for patients their physicians had never met. Teladoc eventually won the case.

The new bill would still require doctors to establish a relationship with telemedicine patients before ordering drugs, but not via a face-to-face visit.

Read the full article: 

Texas to Take a Leap Forward in Telehealth – A Proposed Bill Drops the Controve…

Related Content

Association of 300 telehealth groups urges Congress to extend COVID-era rules
Eli Lilly releases cheaper, single-use vials of weight loss drug
Walmart sells virtual care business to Fabric
AMA will aggressively support permanent telemedicine reimbursement
Telehealth execs face 20 years for $100M Adderall prescription fraud
Telemedicine, remote monitoring help reduce healthcare costs

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup